Skip to main content
logo
BioCryst Pharmaceuticals, Inc. (BCRX)
NASDAQ: BCRX · Real-Time Price · USD
6.93
+0.30 (4.52%)
At close: Oct 20, 2025, 4:00 PM EDT
6.90
-0.03 (-0.42%)
After-hours: Oct 20, 2025, 7:50 PM EDT

BioCryst Pharmaceuticals Revenue

BioCryst Pharmaceuticals had revenue of $163.35M in the quarter ending June 30, 2025, with 49.41% growth. This brings the company's revenue in the last twelve months to $557.51M, up 45.85% year-over-year. In the year 2024, BioCryst Pharmaceuticals had annual revenue of $450.71M with 36.00% growth.

Revenue (ttm)
$557.51M
Revenue Growth
+45.85%
P/S Ratio
2.48
Revenue / Employee
$961,217
Employees
580
Market Cap
1.45B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024450.71M119.30M36.00%
Dec 31, 2023331.41M60.59M22.37%
Dec 31, 2022270.83M113.66M72.31%
Dec 31, 2021157.17M139.36M782.38%
Dec 31, 202017.81M-31.02M-63.53%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group422.82B
Johnson & Johnson92.15B
Merck & Co.63.62B
AbbVie58.33B
AstraZeneca56.50B
Novartis AG55.19B
Eli Lilly and Company53.26B
Novo Nordisk49.11B
Revenue Rankings

BCRX News

More News